Iwabuchi K, Bartel P L, Li B, Marraccino R, Fields S
Department of Molecular Genetics and Microbiology, State University of New York, Stony Brook 11794-5222.
Proc Natl Acad Sci U S A. 1994 Jun 21;91(13):6098-102. doi: 10.1073/pnas.91.13.6098.
p53 is a tumor-suppressor protein that can activate and repress transcription. Using the yeast two-hybrid system, we identified two previously uncharacterized human proteins, designated 53BP1 and 53BP2, that bind to p53. 53BP1 shows no significant homology to proteins in available databases, whereas 53BP2 contains two adjacent ankyrin repeats and a Src homology 3 domain. In vitro binding analyses indicate that both of these proteins bind to the central domain of p53 (residues 80-320) required for site-specific DNA binding. Consistent with this finding, p53 cannot bind simultaneously to 53BP1 or 53BP2 and to a DNA fragment containing a consensus p53 binding site. Unlike other cellular proteins whose binding to p53 has been characterized, both 53BP1 and 53BP2 bind to the wild-type but not to two mutant p53 proteins identified in human tumors, suggesting that binding is dependent on p53 conformation. The characteristics of these interactions argue that 53BP1 and 53BP2 are involved in some aspect of p53-mediated tumor suppression.
p53是一种可激活和抑制转录的肿瘤抑制蛋白。利用酵母双杂交系统,我们鉴定出两种以前未被描述的人类蛋白质,分别命名为53BP1和53BP2,它们可与p53结合。53BP1与现有数据库中的蛋白质无明显同源性,而53BP2含有两个相邻的锚蛋白重复序列和一个Src同源3结构域。体外结合分析表明,这两种蛋白质都与位点特异性DNA结合所需的p53中央结构域(第80 - 320位氨基酸残基)结合。与此发现一致的是,p53不能同时与53BP1或53BP2以及含有共有p53结合位点的DNA片段结合。与其他已被描述的与p53结合的细胞蛋白不同,53BP1和53BP2都与野生型p53结合,但不与在人类肿瘤中鉴定出的两种突变型p53蛋白结合,这表明这种结合依赖于p53的构象。这些相互作用的特征表明,53BP1和53BP2参与了p53介导的肿瘤抑制的某些方面。